What do the topography codes in ICD-O-2 and ICD-O-3 utilize as their basis?

What do the topography codes in ICD-O-2 and ICD-O-3 utilize as their basis?

• A. ICD-9
• B. ICD-9-CM
• C. Both A and B
• D. Neither A nor B

Answer: (D)

The correct response is based on the fact that the topography codes in ICD-O-2 and ICD-O-3 are specific to the classification of tumors and are not directly based on the ICD-9 or ICD-9-CM coding systems. Rather, ICD-O (International Classification of Diseases for Oncology) is a unique classification system specifically created for oncology and is designed to capture the site (topography) and type (morphology) of tumors. ICD-9 and ICD-9-CM are general classification systems used for all health conditions and diseases and do not specifically encompass the needs of oncology data sharing and classification. Therefore, the topography codes in ICD-O-2 and ICD-O-3 serve a distinct purpose that is not derived from either ICD-9 or ICD-9-CM classifications. This underscores the specialized nature of the ICD-O coding systems which focus on cancer-related classifications to enhance data comparability and quality across different cancer registries.

The correct response is based on the fact that the topography codes in ICD-O-2 and ICD-O-3 are specific to the classification of tumors and are not directly based on the ICD-9 or ICD-9-CM coding systems. Rather, ICD-O (International Classification of Diseases for Oncology) is a unique classification system specifically created for oncology and is designed to capture the site (topography) and type (morphology) of tumors.

ICD-9 and ICD-9-CM are general classification systems used for all health conditions and diseases and do not specifically encompass the needs of oncology data sharing and classification. Therefore, the topography codes in ICD-O-2 and ICD-O-3 serve a distinct purpose that is not derived from either ICD-9 or ICD-9-CM classifications. This underscores the specialized nature of the ICD-O coding systems which focus on cancer-related classifications to enhance data comparability and quality across different cancer registries.